Comparable monthly disclosures
Institutional Activity
Where disclosed mutual fund positions are increasing, reducing, opening or closing.
Portfolio increases
Jul 2024 · Ranked across companies with at least 10 comparable portfolios
| Company | Portfolio increases | Comparable change | Portfolios increasing | Portfolios reducing | Comparable portfolios |
|---|---|---|---|---|---|
| Deepak Nitrite Limited DEEPAKNTR | 21 40.4% of comparable | -41,538 | 21 | 2 | 52 |
| Syngene International Limited SYNGENE | 21 51.2% of comparable | +0.13 Cr | 21 | 2 | 41 |
| Mahindra & Mahindra Financial Services Limited M&MFIN | 21 58.3% of comparable | -0.16 Cr | 21 | 3 | 36 |
| Adani Power Limited ADANIPOWER | 21 72.4% of comparable | +0.29 Cr | 21 | 3 | 29 |
| Schaeffler India Limited SCHAEFFLER | 21 31.3% of comparable | +0.09 Cr | 21 | 9 | 67 |
| The Ramco Cements Limited RAMCOCEM | 20 46.5% of comparable | +0.03 Cr | 20 | 0 | 43 |
| Gland Pharma Limited GLAND | 20 40.0% of comparable | -0.07 Cr | 20 | 1 | 50 |
| ZF Commercial Vehicle Control Systems India Limited ZFCVINDIA | 20 34.5% of comparable | +29,126 | 20 | 1 | 58 |
| Atul Limited ATUL | 20 55.6% of comparable | +0.02 Cr | 20 | 2 | 36 |
| Bank of India BANKINDIA | 20 35.7% of comparable | -0.62 Cr | 20 | 3 | 56 |
| Tata Elxsi Limited TATAELXSI | 20 76.9% of comparable | -86,490 | 20 | 3 | 26 |
| BSE Limited BSE | 20 34.5% of comparable | -0.03 Cr | 20 | 4 | 58 |
| IPCA Laboratories Limited IPCALAB | 20 35.1% of comparable | -0.02 Cr | 20 | 4 | 57 |
| United Breweries Limited UBL | 20 33.3% of comparable | +0.07 Cr | 20 | 4 | 60 |
| UPL Limited UPL | 20 58.8% of comparable | -0.09 Cr | 20 | 5 | 34 |
| SHREE CEMENT LIMITED SHREECEM | 20 38.5% of comparable | -0.01 Cr | 20 | 6 | 52 |
| City Union Bank Limited CUB | 20 62.5% of comparable | +1.00 Cr | 20 | 6 | 32 |
| Supreme Industries Limited SUPREMEIND | 20 48.8% of comparable | -0.02 Cr | 20 | 7 | 41 |
| Laurus Labs Limited LAURUSLABS | 20 50.0% of comparable | +0.69 Cr | 20 | 7 | 40 |
| CG Power and Industrial Solutions Limited CGPOWER | 20 38.5% of comparable | -0.05 Cr | 20 | 8 | 52 |
| Aurobindo Pharma Limited AUROPHARMA | 20 27.4% of comparable | -0.14 Cr | 20 | 16 | 73 |
| Sumitomo Chemical India Limited SUMICHEM | 19 52.8% of comparable | +0.28 Cr | 19 | 1 | 36 |
| Adani Energy Solutions Limited ADANIENSOL | 19 61.3% of comparable | +21,259 | 19 | 1 | 31 |
| Indian Railway Finance Corporation Limited IRFC | 19 86.4% of comparable | +0.02 Cr | 19 | 2 | 22 |
| Ajanta Pharma Limited AJANTPHARM | 19 38.0% of comparable | +0.03 Cr | 19 | 4 | 50 |
How to read this activity
Activity compares disclosed positions for economic portfolios observed in both relevant monthly disclosures and adjusts for externally evidenced corporate actions where available.
At least 10 comparable portfolios are required. Companies under corporate-action review are excluded. Counts are unweighted by portfolio size, and share changes are quantities rather than market values; zero counts can appear at the end of a ranking. Breadth change is the change in AMCs holding, and can also reflect reporting coverage.
Full methodology →